Monday 15 June 2026

EPHMRA Conference

Visit event website
25 June 202427 June 2024
London, UKLeonardo Royal London St Paul's
Hosted by the European Pharmaceutical Market Research Association (EPHMRA), this event aims to disseminate knowledge on the best practices for market research.

The conference will include both plenary (main conference room sessions) as well as parallel sessions either in a presentation or ‘fireside chat’ format.



Today's issue

Vivoryon’s kidney reset: CEO Frank Weber on the company’s new focus
Biotechnology
Vivoryon’s kidney reset: CEO Frank Weber on the company’s new focus
15 June 2026
Pharmaceutical
Grifols launches Fesilty in USA for rare bleeding disorder
15 June 2026
Biotechnology
Elicio Thera tanks on disappointing Phase II AMPLIFY-7P study
15 June 2026
Pharmaceutical
Two-year data bolster Neurocrine’s Crenessity case in pediatric CAH
15 June 2026
Biotechnology
J&J’s Talvey combo cuts progression risk in earlier myeloma setting
15 June 2026
Pharmaceutical
Pharmstandard to build large-scale complex for production of live vaccines
15 June 2026
Biotechnology
Positive Phase III results for Intellia’s lonvo-z
15 June 2026


Company Spotlight

A commercial-stage UK biotechnology company that has moved its next-generation CD19 CAR-T therapy AUCATZYL from FDA approval into active revenue generation, while expanding obe-cel into autoimmune disease and pediatric oncology.




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze